Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report-Reference-Cited by-同舟云学术

Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report

Published:2020-06-18 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Botta Cirino,Caruso Nadia,Bossio Sabrina,Storino Francesca,Console Giuseppe,Martino Massimo,Mendicino Francesco,Lucia Eugenio,Morelli Rosellina,Correale Pierpaolo,Morabito Fortunato,Gentile Massimo,Vigna Ernesto

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference20 articles.

1. Ponatinib for treating acute lymphoblastic leukaemia: an evidence review group perspective of a NICE single technology appraisal;Stevenson;Pharmacoeconomics,2018

2. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study;Fielding;Blood,2007

3. Ponatinib-induced graft-versus-host disease/graft-versus-leukemia effect in a patient with philadelphia-positive acute lymphoblastic leukemia without the T315I mutation relapsing after allogeneic transplant;Petrungaro;Chemotherapy,2017

4. The treatment of adults with acute lymphoblastic leukemia;Fielding;Hematol Am Soc Hematol Educ Prog,2008

5. Molecular remission using low-dose immunotherapy for relapsed refractory Philadelphia chromosome-positive precursor B-cell acute lymphoblastic leukemia post-allogeneic stem cell transplant;Maharaj;Fut Sci OA,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Remission Achieved by Modified Donor Lymphocyte Infusion Combined with Chemotherapy and Azacitidine Maintenance Therapy in a Patient with Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review;Advances in Clinical Medicine;2024

2. Multiple drugs;Reactions Weekly;2020-07